In addition, irisin improves glucose and lipid metabolism (3–5) and ameliorates the effects of obesity-driven inflammation, metabolic syndrome, and diabetes (6–8). Here, FNDC5 is linked to obesity due to melanocortin 4 receptor deficiency.